Translate this website into the following languages:
View All Releases >
Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in ...
UC San Diego Health now offers patients with epilepsy another non-pharmacological way to treat seizures. For the more than one million individuals who live with uncontrolled seizures despite taking me ...
Researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health have discovered that a chemical compound that activates ATF6, a gene associated wit ...
Ever wonder why obese bodies burn less calories or why dieting often leads to a plateau in weight loss? In both cases the body is trying to defend its weight by regulating energy expenditure. In a pap ...
Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of Cali ...
View All Features >
Yahir Santiago-Lastra, MD, a urologist trained in neuro-urology and pelvic reconstruction, explains why offering a transitional urology program can increase compliance with disease management and redu ...
A lab at UC San Diego School of Medicine is currently investigating possible interventions to help prevent and treat hypoxic kidney injuries for kidney transplant patients.
A rare brain tumor inspires a patient to become part of the treatment team for those diagnosed with acoustic neuromas.
Ketamine, a medication originally developed as an anesthetic drug, is now being used to address treatment-resistant depression.
In the News
View More >
Features Jerry Shih, MD, and Sharona Ben-Haim, MD
Features Joelle Coletta, MD, Pam Taub, MD, and Ulrika Birgersdotter-Green, MD
Features UC San Diego School of Medicine
Features Lisa Madlensky, PhD